Ling Y. Huw
Ling Y. Huw publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Cancer Genomics and Diagnostics, PI3K/AKT/mTOR signaling in cancer and Colorectal Cancer Treatments and Studies.
- World rank
- #1,209,555 of 7,710,434 ranked researchers
- Rank in United States
- #387,716 of 1,627,098
- Works
- 41
- Citations
- 1.3k
- Citations per work
- 30.7
What does Ling Y. Huw research?
Ling Y. Huw's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (44%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1947.0%
- Health Sciences1844.1%
- Medicine1844.1%
- Everything else26.0%
- Physical Sciences12.9%
- Computer Science12.9%
- 1Molecular Biology29% of their works
- 2Pulmonary and Respiratory Medicine24% of their works
- 3Oncology21% of their works
- 4Cancer Research15% of their works
- 5Artificial Intelligence3% of their works
- 6Immunology3% of their works
Research topics
Which keywords describe Ling Y. Huw's research?
The keywords of their largest research topics: Cancer, Targeted Therapy, Cancer Genomics, Clinical Trials, Genomic Profiling, Molecular Subtypes, mTOR and Mutational Signatures.
- Treatment Response
- Prostate Cancer
- EGFR Mutations
- CDK4/6 Inhibitors
- Androgen Receptor
- KRAS Mutations
- Cetuximab
- Signaling
- Molecular Subtypes
- Clinical Trials
- Targeted Therapy
- Cancer
- Cancer Genomics
- Genomic Profiling
- Mutational Signatures
- mTOR
- Gene Expression
- ALK Inhibitors
- Breast Cancer
- Cell Death
- Ferroptosis
- Breast Tumours
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Cancer62 topics
- Targeted Therapy62 topics
- Cancer Genomics41 topic
- Clinical Trials42 topics
- Genomic Profiling42 topics
- Molecular Subtypes42 topics
- Mutational Signatures41 topic
- Signaling41 topic
- mTOR41 topic
- Cetuximab31 topic
- Gene Expression32 topics
- KRAS Mutations31 topic
- ALK Inhibitors21 topic
- Androgen Receptor21 topic
- Breast Cancer21 topic
- CDK4/6 Inhibitors21 topic
- Cell Death21 topic
- EGFR Mutations21 topic
- Ferroptosis21 topic
- Prostate Cancer21 topic
- Breast Tumours11 topic
- Treatment Response11 topic
Where does Ling Y. Huw work?
Ling Y. Huw's main affiliation in the publication record is Texas Oncology, United States.
How many publications and citations does Ling Y. Huw have?
OpenAlex counts 41 works and 1,257 citations for Ling Y. Huw, an h-index of 7, ranking #1,209,555 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ling Y. Huw. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.